Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 28, 2020Current NeuropharmacologyOpen Access

Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

SKSahil KhanAndhra Pradesh Forest DepartmentKBKalyani BarveNarsee Monjee Institute of Management StudiesMKMaushmi S. KumarUniversity of Lethbridge

Discussion

Loading...

Member takes

Implication

Review highlights diagnostic and therapeutic advancements in patients with Alzheimer's disease, suggesting artificial intelligence and theranostics will guide future care.

Key Points

  • To review current paradigms and emergent advancements in the pathogenesis, diagnostic modalities, and therapeutic approaches for Alzheimer's disease.
  • Narrative synthesis of recent scientific developments concerning Alzheimer's disease mechanisms, biomarkers, and therapeutic modalities.
  • Evaluation of modern technological approaches, specifically neuroimaging protocols, theranostics, and artificial intelligence integration.
  • Biomarkers and advanced brain-imaging modalities represent key tools enabling earlier and more sensitive detection of Alzheimer's pathology.
  • Theranostic strategies combined with artificial intelligence algorithms provide a framework for individualized disease monitoring and targeted clinical intervention.

Cite This Study

Khan et al. (2020) studied this question.

synapsesocial.com/papers/69d80d0333ca018b39ae3202https://doi.org/10.2174/1570159x18666200528142429
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome2018 · 720 citations
  2. 2Forecasting the progression of Alzheimer's disease using neural networks and a novel preprocessing algorithm.2019 · 106 citations
  3. 3Oxidative stress and the amyloid beta peptide in Alzheimer’s disease2017 · 2,213 citations